Association of uricemia with biochemical and dietary factors in human adults with metabolic syndrome genotyped to C677T polymorphism in the methylenetetrahydrofolate reductase gene;Asociación de la uricemia con factores bioquímicos y dietéticos en humanos adultos con síndrome metabólico genotipados para el polimorfismo c677t en el gen metilenotetrahidrofolato reductasa

Nutricion Hospitalaria

Volumn 26, Issue 2, 2011, Pages 298-303

  Kimi Uehara, S ^a   Rosa, Glorimar ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

C677T polymorphism in the MTHFR gene; Cardiovascular disease; Metabolic syndrome; Uricemia

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CROSS-SECTIONAL STUDY; DIET; DRINKING BEHAVIOR; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HYPERURICEMIA; LIFESTYLE; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PHYSIOLOGY; WAIST CIRCUMFERENCE;

ADULT; ALCOHOL DRINKING; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDIES; DIET; FEMALE; GENOTYPE; HUMANS; HYPERURICEMIA; LIFE STYLE; MALE; METABOLIC SYNDROME X; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; WAIST CIRCUMFERENCE;

EID: 79955537387     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2011.26.2.4817     Document Type: Article

References (34)

1. Hayden MR, Tyagi S. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutrition & Metabolism 2004; 1: 1-15.
2. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006; 54 (8): 2688-96.
3. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116: 894-900.
4. Gagliardi ACM, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009; 201 (1): 11-7.
5. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Inter Med 1999; 131: 7-13.
6. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000; 10: 136-43.
7. Vuorinen-Markkola H, Yki-Järvine H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25-9.
8. Hong YS, Lee MJ, Kim KH, Lee SH, Lee YH, Kim BG, Jeong B, Yoon HR, Nishio H, et al. The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men. J Korean Med Sci 2004; 19: 209-13.
9. Golbahar J, Aminzadeh MA, Al-Shboul QM, Kassab S, Rezain GR. Association of methylenetetrahydrofolate reductase gene (C677T) polymorphism with hyperuricemia. Nutr Metab Cardiovasc Dis 2007; 17: 462-7.
10. Ministério da Saúde, Secretaria de Vigilância em Saúde. Saúde Brasil 2007: Uma Análise da Situação de Saúde. Perfil de mortalidade do Brasileiro, Novembro 2008. Available at: http:// portal.saude.gov.br/portal/arquivos/pdf/coletiva_saude_061008.pdf. Accessed: 13/07/2009
11. a Ed. Prentice Hall; 1999, pp. 385-6.
12. International Diabetes Foundation. The consensus worldwide definition of the Metabolic Syndrome. Disponível em: http:// www.idf.org e Acesso em: 13/01/2006.
13. Sichieri R. Estudo de validação do questionário de frequência de consumo de alimentos. In: Sichieri R. Epidemiologia da obesidade. Rio de Janeiro: Ed. UERJ; 1998, pp. 25-34.
14. Gibson RS. Principles of nutritional assessment. 2. ed. New York: Oxford University Press Inc, 2005. 928 p.
15. WHO. Obesity: prevention and managing the global epidemic: report of a WHO consulation on obesity. Geneva; 1998.
16. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Illinois: Human Kinetics; 1988.
17. Durmin JV, Womersly J. Body fat assessed from total total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-94.
18. Sociedade Brasileira de Cardiologia. IV Diretrizes Brasileiras de Hipertensão Arterial. Arq Bras Cardiol 2004; 82 (Suppl. 4): 1-14.
19. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Matthews DR, Hosker JP, Rudenski BA, Naylor DF, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and a-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
21. Ubbink JB, Hayward-Vermaak WJ, Bissbort S. Rapid highperformance liquid chromatografhic assay for total homocysteine levels in human serum. J Chromatogr 1991; 365: 441-6.
22. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensix material. Biotechniques 1991; 10: 506-13.
23. Mutchinick OM, López MA, Luna L, Waxman J, Babinsky VE, Ryvemce Collaborative Group. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 1999; 68: 461-7.
24. Emery AEH. Hardy-Weinberg equilibrium and the estimation of gene frequencies. In: Emery AEH Editor. Methodology in Medical Genetics: An Introduction to Statistical Methods. Churchill Livingstone, Edinburgh; 1976, pp. 3-9.
25. FAO/WHO/UNU expert consultation. Protein and mino acid requirements in human nutrition. WHO technical report series; no 935.
26. Geloneze B, Geloneze SR, Ermetice MN, Repetto EM, Tambascia MA. The threshold value for insulin resistance (HOMAIR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study, Diabetes Res Clin Pract 2006; 24: 219-20.
27. Institute of Medicine/Food And Nutrition Board. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and coline. Washington (DC): National Academy Press; 1998.
28. Omenn GS, Beresford SAA, Motulsky AG. Preventing coronary heart disease-B vitamins and homocysteine. Circulation1998; 97: 421-4.
29. Moriwaki Y, Yamamoto T, Takahashi S, Tsutsumi Z, Higashino K. Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia. Ann Rheum Dis 1995; 54: 351-4.
30. Cardona F, Tinahones FJ, Collantes E, Escudero A, García-Fuentes E, Soriguer FJ. The elevated prevalence of apoliprotein E2 in patients with gout is associated with reduced renal excretion of urates. Rheumatology 2003; 42: 468-72.
31. Tinahones JF, Pérez-Lindón G, C-Soriguer FJ, Pareja A, Sánchez-Guijo P, Collantes E. Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab 1997; 82: 1188-91.
32. Bailey LB, Gregory JF. Polymorphisms of methylene tetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 1999; 129: 919-22.
33. Yamamoto T, Moriwaki Y, Takahashi S. Effect of ethanol on metabolism of purine bases (hypoxanthine, xanthine, and uric acid). Clin Chim Acta 2005; 356: 35-7.
34. Choi HK, Atkinson K, Karison EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363: 1277-81.